Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
Maarouf C, Beach T, Adler C, Shill H, Sabbagh M, Wu T, Walker D, Kokjohn T, Roher A, Consortium A. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects. Neurological Research 2012, 34: 669-676. PMID: 22889670, PMCID: PMC3681206, DOI: 10.1179/1743132812y.0000000063.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overApolipoprotein A-IApolipoproteins EBiomarkersClusterinCohort StudiesFemaleFibrinogenGlutathione S-Transferase piHumansMaleMiddle AgedParkinson DiseasePrealbuminProtein IsoformsTwo-Dimensional Difference Gel ElectrophoresisConceptsParkinson's diseaseCerebrospinal fluidPostmortem ventricular cerebrospinal fluidCerebrospinal fluid biomarkersNormal control subjectsYears of ageVentricular cerebrospinal fluidPD patientsFluid biomarkersControl subjectsConsensus panelDefinitive biomarkersApolipoprotein EPD casesPD pathogenesisPotential biomarkersClinical diagnosisNeurodegenerative disordersApolipoprotein ADiseaseModifying treatmentsTwo-dimensional difference gel electrophoresisBiomarkersDiagnostic toolDifference gel electrophoresis